TŮMOVÁ, Lucie, Antonio POMBINHO, Martina VOJTĚCHOVÁ, Jitka STANČÍKOVÁ, Dietmar GRADL, Michaela KRAUSOVÁ, Eva ŠLONCOVÁ, Monika HORÁZNÁ, Vítězslav KŘÍŽ, Olga MACHOŇOVÁ, Jindřich JINDŘICH, Zbyněk ZDRÁHAL, Petr BARTŮNĚK and Vladimír KOŘÍNEK. Monensin Inhibits Canonical Wnt Signaling in Human Colorectal Cancer Cells and Suppresses Tumor Growth in Multiple Intestinal Neoplasia Mice. Molecular Cancer Therapeutics. Philadelphia: American Association for Cancer Research, 2014, vol. 13, No 4, p. 812-822. ISSN 1535-7163. Available from: https://dx.doi.org/10.1158/1535-7163.MCT-13-0625.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Monensin Inhibits Canonical Wnt Signaling in Human Colorectal Cancer Cells and Suppresses Tumor Growth in Multiple Intestinal Neoplasia Mice
Authors TŮMOVÁ, Lucie (203 Czech Republic), Antonio POMBINHO (620 Portugal), Martina VOJTĚCHOVÁ (203 Czech Republic), Jitka STANČÍKOVÁ (203 Czech Republic), Dietmar GRADL (276 Germany), Michaela KRAUSOVÁ (203 Czech Republic), Eva ŠLONCOVÁ (203 Czech Republic), Monika HORÁZNÁ (203 Czech Republic), Vítězslav KŘÍŽ (203 Czech Republic), Olga MACHOŇOVÁ (203 Czech Republic), Jindřich JINDŘICH (203 Czech Republic), Zbyněk ZDRÁHAL (203 Czech Republic, guarantor, belonging to the institution), Petr BARTŮNĚK (203 Czech Republic) and Vladimír KOŘÍNEK (203 Czech Republic).
Edition Molecular Cancer Therapeutics, Philadelphia, American Association for Cancer Research, 2014, 1535-7163.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.683
RIV identification code RIV/00216224:14740/14:00075743
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1158/1535-7163.MCT-13-0625
UT WoS 000334342300005
Keywords in English BETA-CATENIN; CYCLE ARREST; COLON-CANCER; CARCINOMA-CELLS; LEUKEMIA-CELLS; IN-VIVO; APOPTOSIS; ACTIVATION; APC; GENES
Tags kontrola MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 26/9/2014 11:18.
Abstract
The Wnt signaling pathway is required during embryonic development and for the maintenance of homeostasis in adult tissues. However, aberrant activation of the pathway is implicated in a number of human disorders, including cancer of the gastrointestinal tract, breast, liver, melanoma, and hematologic malignancies. In this study, we identified monensin, a polyether ionophore antibiotic, as a potent inhibitor of Wnt signaling. The inhibitory effect of monensin on the Wnt/beta-catenin signaling cascade was observed in mammalian cells stimulated with Wnt ligands, glycogen synthase kinase-3 inhibitors, and in cells transfected with beta-catenin expression constructs. Furthermore, monensin suppressed the Wnt-dependent tail fin regeneration in zebrafish and Wnt- or beta-catenin-induced formation of secondary body axis in Xenopus embryos. In Wnt3a-activated HEK293 cells, monensin blocked the phoshorylation of Wnt coreceptor low-density lipoprotein receptor related protein 6 and promoted its degradation. In human colorectal carcinoma cells displaying deregulated Wnt signaling, monensin reduced the intracellular levels of beta-catenin. The reduction attenuated the expression of Wnt signaling target genes such as cyclin D1 and SP5 and decreased the cell proliferation rate. In multiple intestinal neoplasia (Min) mice, daily administration of monensin suppressed progression of the intestinal tumors without any sign of toxicity on normal mucosa. Our data suggest monensin as a prospective anticancer drug for therapy of neoplasia with deregulated Wnt signaling.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 8/6/2024 06:16